Do competing demands of physical illness in type 2 diabetes influence depression screening, documentation and management in primary care: a cross-sectional analytic study in Aboriginal and Torres Strait Islander primary health care settings.
Loading...
Date
2013-06-26
Author(s)
Journal Title
Journal ISSN
Volume Title
Publisher
Affiliation(s)
(Schierhout, Nagel, Bailie) Menzies School of Health Research, Institute of Advanced Studies, Charles Darwin University, Darwin, Australia
(Connors) Northern Territory Department of Health, Darwin, Australia
(Si) Centre for Chronic Disease, School of Medicine, University of Queensland, Brisbane, Australia
(Brown) Baker IDI, Central Australia, Alice Springs, Australia
(Connors) Northern Territory Department of Health, Darwin, Australia
(Si) Centre for Chronic Disease, School of Medicine, University of Queensland, Brisbane, Australia
(Brown) Baker IDI, Central Australia, Alice Springs, Australia
Year
2013
Citation
International Journal of Mental Health Systems. Vol.7(1), 2013.
Journal
International Journal of Mental Health Systems
Conference name
Conference location
Grant information
The ABCD National Research Partnership Project is supported by funding from the Australian National Health and Medical Research Council (ID No.545267) and the Lowitja Institute, and by in-kind and financial support from a range of Community Controlled and Government agencies.
Abstract
Background: Relatively little is known about how depression amongst people with chronic illness is identified and managed in diverse primary health care settings. We evaluated the role of complex physical needs in influencing current practice of depression screening, documentation and antidepressant prescriptions during a 12-month period, among adults with Type 2 diabetes attending Aboriginal and Torres Strait Islander primary care health centres in Australia. Method(s): We analysed clinical audit data from 44 health centres participating in a continuous quality improvement initiative, using previously reported standard sampling and data extraction protocols. Eligible patients were those with Type 2 diabetes with health centre attendance within the past 12 months. We compared current practice in depression screening, documentation and antidepressant prescription between patients with different disease severity and co-morbidity. We used random effects multiple logistic regression models to adjust for potential confounders and for clustering by health centre. Result(s): Among the 1174 patients with diabetes included, median time since diagnosis was 7 years, 19% of patients had a co-existing diagnosis of Ischaemic Heart Disease and 1/3 had renal disease. Some 70% of patients had HbAc1>7.0%; 65% had cholesterol >4.0 mmol1-1 and 64% had blood pressure>130/80 mmHg. Documentation of screening for depression and of diagnosed depression were low overall (5% and 6% respectively) and lower for patients with renal disease (Adjusted odds ratio [AOR] 0.21; 95% confidence interval [CI] 0.14 to 0.31 and AOR 0.34; 95% CI 0.15 to 0.75), and for those with poorly controlled disease (HbA1c>7.00 (AOR 0.40; 95% CI 0.23 to 0.68 and AOR 0.51; 95% CI 0.30 to 84)). Screening for depression was lower for those on pharmaceutical treatment for glycaemic control compared to those not on such treatment. Antidepressant prescription was not associated with level of diabetes control or disease severity. Conclusion(s): Background levels of depression screening and documentation were low overall and significantly lower for patients with greater disease severity. Strategies to improve depression care for vulnerable populations are urgently required. An important first step in the Australian Indigenous primary care context is to identify and address barriers to the use of current clinical guidelines for depression screening and care. © 2013 Schierhout et al.; licensee BioMed Central Ltd.
PubMed ID
Type
Article
Study type
Observational study (cohort, case-control, cross sectional, or survey)
Subjects
Mental health
Disability
Disability